Correlation Between Sonnet Biotherapeutics and CytomX Therapeutics
Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and CytomX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and CytomX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and CytomX Therapeutics, you can compare the effects of market volatilities on Sonnet Biotherapeutics and CytomX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of CytomX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and CytomX Therapeutics.
Diversification Opportunities for Sonnet Biotherapeutics and CytomX Therapeutics
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between Sonnet and CytomX is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and CytomX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CytomX Therapeutics and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with CytomX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CytomX Therapeutics has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and CytomX Therapeutics go up and down completely randomly.
Pair Corralation between Sonnet Biotherapeutics and CytomX Therapeutics
Given the investment horizon of 90 days Sonnet Biotherapeutics Holdings is expected to generate 1.77 times more return on investment than CytomX Therapeutics. However, Sonnet Biotherapeutics is 1.77 times more volatile than CytomX Therapeutics. It trades about 0.05 of its potential returns per unit of risk. CytomX Therapeutics is currently generating about -0.03 per unit of risk. If you would invest 154.00 in Sonnet Biotherapeutics Holdings on November 18, 2024 and sell it today you would earn a total of 5.00 from holding Sonnet Biotherapeutics Holdings or generate 3.25% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sonnet Biotherapeutics Holding vs. CytomX Therapeutics
Performance |
| Timeline |
| Sonnet Biotherapeutics |
| CytomX Therapeutics |
Sonnet Biotherapeutics and CytomX Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sonnet Biotherapeutics and CytomX Therapeutics
The main advantage of trading using opposite Sonnet Biotherapeutics and CytomX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, CytomX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CytomX Therapeutics will offset losses from the drop in CytomX Therapeutics' long position.| Sonnet Biotherapeutics vs. ZyVersa Therapeutics | Sonnet Biotherapeutics vs. Allarity Therapeutics | Sonnet Biotherapeutics vs. Immix Biopharma | Sonnet Biotherapeutics vs. Cns Pharmaceuticals |
| CytomX Therapeutics vs. Spero Therapeutics | CytomX Therapeutics vs. Instil Bio | CytomX Therapeutics vs. NextCure | CytomX Therapeutics vs. Assembly Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |